More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$1.42B
EPS
2.5
P/E ratio
15.7
Price to sales
1.02
Dividend yield
1.375%
Beta
0.427896
Previous close
$35.02
Today's open
$34.90
Day's range
$34.26 - $35.64
52 week range
$28.25 - $60.08
show more
CEO
Jack Clifford Bendheim
Employees
2605
Headquarters
Teaneck, NJ
Exchange
NASDAQ Global Market
Shares outstanding
40601603
Issue type
Common Stock
Healthcare
Pharmaceuticals
Interpreting Phibro (PAHC) International Revenue Trends
Examine the evolution of Phibro's (PAHC) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Zacks Investment Research • Nov 9, 2026

Phibro Animal Health Corporation (PAHC) Q1 2027 Earnings Call Transcript
Phibro Animal Health Corporation ( PAHC ) Q1 2027 Earnings Call November 5, 2026 9:00 AM EST Company Participants Glenn David - Chief Financial Officer Patrick Rodriguez - Vice President of Finance & Treasurer Daniel Bendheim - CEO, President & Director Larry Miller - Chief Operating Officer Conference Call Participants Ekaterina Knyazkova - JPMorgan Chase & Co, Research Division Curtis Moiles - BNP Paribas, Research Division Presentation Operator Hello, everyone. Thank you for joining us, and welcome to Phibro Animal Health Corporation to host webcast and conference call on first quarter results.
Seeking Alpha • Nov 7, 2026

What Phibro Animal Health (PAHC) Said on Its Q1 Earnings Call
Phibro Animal Health NASDAQ: PAHC reported a 6% increase in fiscal first-quarter sales, helped by growth in its Mineral Nutrition and Performance Products businesses, and maintained its full-year outlook despite pressure on poultry producers.
MarketBeat • Nov 5, 2026

Phibro Animal Health Corporation Reports First Quarter Results, Maintains Financial Guidance
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its first quarter ended September 30, 2026 and maintained its financial guidance for the year ending June 30, 2027. Highlights for the three months ended September 30, 2026 (compared to the three months ended September 30, 2025) Net sales of $386.8 million, an increase of $22.9 million, or 6% Net income of $29.5 million, an increase of $3.0 million, o.
Business Wire • Nov 4, 2026

Phibro Animal Health (PAHC) Q1 Earnings Match Estimates
Phibro Animal Health (PAHC) came out with quarterly earnings of $0.79 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.73 per share a year ago.
Zacks Investment Research • Nov 4, 2026

Phibro (PAHC) Reports Q1 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Phibro (PAHC) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks Investment Research • Nov 5, 2026

Phibro Animal Health Corporation Declares Quarterly Dividend
TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 16, 2026, to stockholders of record at the close of business on November 25, 2026. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner w.
Business Wire • Nov 3, 2026

Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its first quarter financial results on Wednesday, November 4, 2026, after the market closes. Phibro management will host a conference call and webcast on Thursday, November 5, 2026, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (83.
Business Wire • Oct 28, 2026

Phibro Animal Health (PAHC) Earnings Expected to Grow: Should You Buy?
Phibro (PAHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Investment Research • Oct 28, 2026

Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Investment Research • Oct 27, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Phibro Animal Health Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.